ANDA 78688, held by Natco Pharma. Bendroflumethiazide; Nadolol.
As of Nov 15, 2026, ANDA 78688 (Nadolol And Bendroflumethiazide), held by Natco Pharma, was first approved by FDA on Feb 15, 2008, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 15, 2008 | Original application | Approved | None posted |
| Nadolol And Bendroflumethiazide5MG;40MG · tablet;oral | Bendroflumethiazide; Nadolol | Discontinued |
| Nadolol And Bendroflumethiazide5MG;80MG · tablet;oral | Bendroflumethiazide; Nadolol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
